Journal article
The Hemoglobin A1c Level as a Progressive Risk Factor for Cardiovascular Death, Hospitalization for Heart Failure, or Death in Patients With Chronic Heart Failure: An Analysis of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program
Abstract
BACKGROUND: A progressive relationship between hemoglobin A(1c) (HbA(1c)) levels and cardiovascular (CV) events has been observed in persons with and without diabetes. To our knowledge, the nature of such a relationship in patients with symptomatic chronic heart failure (HF) has not been studied.
METHODS: A total of 2412 participants (907 with prior diabetes) in the Candesartan in Heart failure: Assessment of Reduction in Mortality and …
Authors
Gerstein HC; Swedberg K; Carlsson J; McMurray JJV; Michelson EL; Olofsson B; Pfeffer MA; Yusuf S
Journal
JAMA Internal Medicine, Vol. 168, No. 15, pp. 1699–1704
Publisher
American Medical Association (AMA)
Publication Date
August 11, 2008
DOI
10.1001/archinte.168.15.1699
ISSN
2168-6106